📊 Score Breakdown
Offering Ability
90
Cash Runway
10
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
33%
📉 Score Deterioration
40%
• Score rose 16 points recently (worsening)
🔄 Reverse Split
30%
• 50-day avg $1.25 approaching $1 threshold
💰 Capital Raise
20%
• Active shelf registration ($300M, 385% of market cap)
💹 Market Data
Market Cap$78.02M
Shares Outstanding61.92M
Float60.23M
Cash$170.89M
Debt$28.78M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 5.0% shares (2025Q4 vs prior)
97 institutional holders · 51.11M shares
#1
TANG CAPITAL MANAGEMENT LLC
6.14M shares
#2
Blue Owl Capital Holdings LP
5.94M shares
#3
VANGUARD GROUP INC
2.82M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.44M
Days to Cover10.4
% of Float5.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2020
EFFECT
EFFECT
Apr 06, 2026
S-3
SHELF
Mar 30, 2026
8-K
8K EVENT
Mar 30, 2026
4
INSIDER TRANSACTION
Jan 26, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for PLRX
📊 PLRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 PLRX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.